Cargando…
The immunologically high-risk kidney recipient in the early post-COVID-19 period. To do or not to do? A case report
Kidney transplantation is nowadays the treatment of choice for end-stage kidney disease (ESKD), and it is the most performed organ transplantation. During the COVID-19 pandemic, kidney-transplant recipients appeared to be at higher risk of morbidity and mortality due to severe forms of illness. The...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076652/ https://www.ncbi.nlm.nih.gov/pubmed/37035338 http://dx.doi.org/10.3389/fmed.2023.1147835 |
_version_ | 1785020178764922880 |
---|---|
author | Antal, Oana Daciana Elec, Alina Muntean, Adriana Moisoiu, Tudor Melinte, Razvan Marian Elec, Florin Ioan |
author_facet | Antal, Oana Daciana Elec, Alina Muntean, Adriana Moisoiu, Tudor Melinte, Razvan Marian Elec, Florin Ioan |
author_sort | Antal, Oana |
collection | PubMed |
description | Kidney transplantation is nowadays the treatment of choice for end-stage kidney disease (ESKD), and it is the most performed organ transplantation. During the COVID-19 pandemic, kidney-transplant recipients appeared to be at higher risk of morbidity and mortality due to severe forms of illness. The result was a decrease in the number of solid organs transplants worldwide, with patients' reduced chance of receiving transplants. The best timing for surgery after COVID-19 infection is still controversial since most of the available data come from study periods with zero or low prevalence of vaccination and COVID-19 variants with high mortality rates. The American Society of Anesthesiologists (ASA) and the Anesthesia Patient Safety Foundation (APSF) Joint Statement on Elective Surgery/Procedures and Anesthesia for Patients after COVID-19 Infection states that elective surgery should be delayed for 7 weeks after a SARS-CoV-2 infection in unvaccinated patients while making no clear statement for vaccinated ones, or those which have already been infected with the virus. Kidney transplant, as opposed to tissue transplant, is not an elective surgery, so the question raised is whether to do it or not. We present the case of a hyper-immunized 47-year-old male patient with end-stage chronic kidney disease who received a second kidney transplant, despite having a mild SARS-COV 2 infection just 2 weeks before his transplantation surgery. |
format | Online Article Text |
id | pubmed-10076652 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100766522023-04-07 The immunologically high-risk kidney recipient in the early post-COVID-19 period. To do or not to do? A case report Antal, Oana Daciana Elec, Alina Muntean, Adriana Moisoiu, Tudor Melinte, Razvan Marian Elec, Florin Ioan Front Med (Lausanne) Medicine Kidney transplantation is nowadays the treatment of choice for end-stage kidney disease (ESKD), and it is the most performed organ transplantation. During the COVID-19 pandemic, kidney-transplant recipients appeared to be at higher risk of morbidity and mortality due to severe forms of illness. The result was a decrease in the number of solid organs transplants worldwide, with patients' reduced chance of receiving transplants. The best timing for surgery after COVID-19 infection is still controversial since most of the available data come from study periods with zero or low prevalence of vaccination and COVID-19 variants with high mortality rates. The American Society of Anesthesiologists (ASA) and the Anesthesia Patient Safety Foundation (APSF) Joint Statement on Elective Surgery/Procedures and Anesthesia for Patients after COVID-19 Infection states that elective surgery should be delayed for 7 weeks after a SARS-CoV-2 infection in unvaccinated patients while making no clear statement for vaccinated ones, or those which have already been infected with the virus. Kidney transplant, as opposed to tissue transplant, is not an elective surgery, so the question raised is whether to do it or not. We present the case of a hyper-immunized 47-year-old male patient with end-stage chronic kidney disease who received a second kidney transplant, despite having a mild SARS-COV 2 infection just 2 weeks before his transplantation surgery. Frontiers Media S.A. 2023-03-23 /pmc/articles/PMC10076652/ /pubmed/37035338 http://dx.doi.org/10.3389/fmed.2023.1147835 Text en Copyright © 2023 Antal, Daciana Elec, Muntean, Moisoiu, Melinte and Elec. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Antal, Oana Daciana Elec, Alina Muntean, Adriana Moisoiu, Tudor Melinte, Razvan Marian Elec, Florin Ioan The immunologically high-risk kidney recipient in the early post-COVID-19 period. To do or not to do? A case report |
title | The immunologically high-risk kidney recipient in the early post-COVID-19 period. To do or not to do? A case report |
title_full | The immunologically high-risk kidney recipient in the early post-COVID-19 period. To do or not to do? A case report |
title_fullStr | The immunologically high-risk kidney recipient in the early post-COVID-19 period. To do or not to do? A case report |
title_full_unstemmed | The immunologically high-risk kidney recipient in the early post-COVID-19 period. To do or not to do? A case report |
title_short | The immunologically high-risk kidney recipient in the early post-COVID-19 period. To do or not to do? A case report |
title_sort | immunologically high-risk kidney recipient in the early post-covid-19 period. to do or not to do? a case report |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076652/ https://www.ncbi.nlm.nih.gov/pubmed/37035338 http://dx.doi.org/10.3389/fmed.2023.1147835 |
work_keys_str_mv | AT antaloana theimmunologicallyhighriskkidneyrecipientintheearlypostcovid19periodtodoornottodoacasereport AT dacianaelecalina theimmunologicallyhighriskkidneyrecipientintheearlypostcovid19periodtodoornottodoacasereport AT munteanadriana theimmunologicallyhighriskkidneyrecipientintheearlypostcovid19periodtodoornottodoacasereport AT moisoiutudor theimmunologicallyhighriskkidneyrecipientintheearlypostcovid19periodtodoornottodoacasereport AT melinterazvanmarian theimmunologicallyhighriskkidneyrecipientintheearlypostcovid19periodtodoornottodoacasereport AT elecflorinioan theimmunologicallyhighriskkidneyrecipientintheearlypostcovid19periodtodoornottodoacasereport AT antaloana immunologicallyhighriskkidneyrecipientintheearlypostcovid19periodtodoornottodoacasereport AT dacianaelecalina immunologicallyhighriskkidneyrecipientintheearlypostcovid19periodtodoornottodoacasereport AT munteanadriana immunologicallyhighriskkidneyrecipientintheearlypostcovid19periodtodoornottodoacasereport AT moisoiutudor immunologicallyhighriskkidneyrecipientintheearlypostcovid19periodtodoornottodoacasereport AT melinterazvanmarian immunologicallyhighriskkidneyrecipientintheearlypostcovid19periodtodoornottodoacasereport AT elecflorinioan immunologicallyhighriskkidneyrecipientintheearlypostcovid19periodtodoornottodoacasereport |